Recombinant multi-species cIAP1/BIRC2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine cIAP1/BIRC2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a member of a family of proteins that inhibits apoptosis by binding to tumor necrosis factor receptor-associated factors TRAF1 and TRAF2, probably by interfering with activation of ICE-like proteases. This encoded protein inhibits apoptosis induced by serum deprivation and menadione, a potent inducer of free radicals. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2012]
The Alternative Names of target: API1,Api1,Api2,BIRC2,Baculoviral IAP repeat-containing protein 2,Birc2,Birc3,C-IAP1,C330006D17Rik,Cellular inhibitor of apoptosis 1 (C-IAP1),HIAP1,HIAP2,Hiap-2,IAP homolog B,IAP1,IAP2,Inhibitor of apoptosis protein 2 (hIAP-2,MIAP1,MIAP2,MIHB,MIHC,RING finger protein 48,RING-type E3 ubiquitin transferase BIRC2,RNF48,TNFR2-TRAF-signaling complex protein 2,c-IAP1,cIAP1,cIAP2,hIAP2),mcIAP1,rIAP1

Target products collectionGo to cIAP1/BIRC2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T84780-Ag-1/ GM-Tg-hg-T84780-Ag-2 Human cIAP1/BIRC2 protein Human
GM-Tg-rg-T84780-Ag-1/ GM-Tg-rg-T84780-Ag-2 Rat cIAP1/BIRC2 protein Rat
GM-Tg-mg-T84780-Ag-1/ GM-Tg-mg-T84780-Ag-2 Mouse cIAP1/BIRC2 protein Mouse
GM-Tg-cynog-T84780-Ag-1/ GM-Tg-cynog-T84780-Ag-2 Cynomolgus/Rhesus macaque cIAP1/BIRC2 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T84780-Ag-1/ GM-Tg-felg-T84780-Ag-2 Feline cIAP1/BIRC2 protein Feline
GM-Tg-cang-T84780-Ag-1/ GM-Tg-cang-T84780-Ag-2 Canine cIAP1/BIRC2 protein Canine
GM-Tg-bovg-T84780-Ag-1/ GM-Tg-bovg-T84780-Ag-2 Bovine cIAP1/BIRC2 protein Bovine
GM-Tg-equg-T84780-Ag-1/ GM-Tg-equg-T84780-Ag-2 Equine cIAP1/BIRC2 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T84780-Ag-1/ GM-Tg-hg-T84780-Ag-2; GM-Tg-rg-T84780-Ag-1/ GM-Tg-rg-T84780-Ag-2;
GM-Tg-mg-T84780-Ag-1/ GM-Tg-mg-T84780-Ag-2; GM-Tg-cynog-T84780-Ag-1/ GM-Tg-cynog-T84780-Ag-2;
GM-Tg-felg-T84780-Ag-1/ GM-Tg-felg-T84780-Ag-2; GM-Tg-cang-T84780-Ag-1/ GM-Tg-cang-T84780-Ag-2;
GM-Tg-bovg-T84780-Ag-1/ GM-Tg-bovg-T84780-Ag-2; GM-Tg-equg-T84780-Ag-1/ GM-Tg-equg-T84780-Ag-2
Products Name cIAP1/BIRC2 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name cIAP1/BIRC2
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine cIAP1/BIRC2 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.